Back to results
US 8,575,221 B2Granted
Derivatives of dimethylcurcumin
AssigneeConcert Pharmaceuticals, Inc.
InventorsCraig E. Masse, Roger D. Tung
Life of this patent
Estimating the term…
Abstract
The invention relates to compounds of Formula I or Ia as disclosed herein: or pharmaceutically acceptable salts thereof or tautomers thereof.
Claims18
A compound of Formula I:
- or a pharmaceutically acceptable salt thereof or a tautomer thereof,
- wherein:
- R1, R2, R3 and R4 are each independently selected from the group consisting of —OH, —O(C1-C6 alkyl), —NO2, —NH2, —NH(C1-C6 alkyl) and —N(C1-C6 alkyl)2, wherein each C1-C6 alkyl is optionally and independently substituted with one or more deuterium;
- R5 and R6 are each independently hydrogen, deuterium, halo, or —NO2;
- R7 is hydrogen, deuterium, or —R13;
- R13 is (C2-C6) alkenyl optionally substituted with one or more deuterium and substituted with —C(O)R12;
- R12 is —OCH3, —OCH2CH3, —NH(CH2CH3), —CN, or —CH2OH, wherein each of —OCH3, —OCH2CH3, —NH(CH2CH3), and —CH2OH is optionally substituted with one or more deuterium;
- R8 and R11 are each independently hydrogen or deuterium;
- R9 and R10 are each independently hydrogen or deuterium;
- X1 and X2 are each independently CH, CD, C(OCH3), C(OCD3) or C(NO2);
- provided that at least one of R1, R2, R3, R4, R5, R6, R7, R8, R11, R9, R10, X1 and X2 comprises deuterium;
- and provided that the compound of Formula I is not
9 more elements
Dependencies are inferred from the claim text.